Every earnings call for ARTEMISMED — management tone, guidance, KPIs and promise tracking, quarter by quarter.
ARTEMISMED · 3 transcripts · Healthcare · latest Q4 FY26Artemis Medicare Services Limited has 3 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue (FY26) ₹1,081 cr (+15% YoY); EBITDA (FY26) ₹218 cr; EBITDA Margin (FY26) 20.2%. Consolidated revenue for FY26 grew 15.4% YoY to INR 1,081 crores.
Read full transcript & analysisRevenue (Q3 FY26) ₹272 cr (+17% YoY); EBITDA (Q3 FY26) ₹52 cr; EBITDA Margin (Q3 FY26) 19.1%. Q3 FY26 Revenue from operations: INR 272 crores, 17.2% YoY growth.
Read full transcript & analysisRevenue ₹275 cr (+14% YoY); EBITDA ₹58 cr; EBITDA Margin 21.2%. Consolidated revenue for Q2 FY26 was INR 274.7 crores, reflecting a 13.8% Y-o-Y growth.
Read full transcript & analysis